Elevance Health, Inc. (NYSE:ELV) Receives $510.38 Average Price Target from Analysts
Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have earned a consensus rating of “Moderate Buy” from the seventeen analysts that are currently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and thirteen have issued a buy recommendation on the company. The average 1 […]
Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have earned a consensus rating of “Moderate Buy” from the seventeen analysts that are currently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and thirteen have issued a buy recommendation on the company. The average 1 […]
